Simpler Grants.gov #RFA-DA-26-034

NIH Grant for Research on Acute Exposure to Ultra-Potent Synthetic Opioids

This opportunity is a research grant from the National Institutes of Health (NIH) focused on the health impacts of acute exposure to ultra-potent synthetic opioids. - Government Buyer: - National Institutes of Health (NIH) - Products/Services Requested: - Basic research services investigating the immediate and persistent effects of exposure to ultra-potent synthetic opioids (UPS opioids) - Target substances include fentanyl, carfentanil, nitazenes, and combinations such as fentanyl and xylazine - OEMs and Vendors: - No specific OEMs or commercial vendors are named, as this is a research grant - Notable Requirements: - Research must address both immediate and delayed pathophysiological effects of UPS opioid exposure - Eligible applicants include government entities, educational institutions, businesses, and nonprofits (with some restrictions for non-domestic entities) - Minimum grant award is $300,000 - Funding is provided under multiple NIH assistance listings related to drug use, addiction, infectious diseases, blood diseases, sleep disorders, lung diseases, cardiovascular diseases, and translational science - No specific products, part numbers, or quantities are specified, as this is a research funding opportunity

Description

This funding opportunity supports research to understand and mitigate the harmful effects of acute exposure to Ultra-Potent Synthetic opioids such as fentanyl, carfentanil, and nitazenes, including their combinations like fentanyl and xylazine. It also supports research on the persistent or delayed pathophysiological effects following such exposure. The program is funded by the National Institutes of Health and aims to advance knowledge in drug use and addiction, infectious diseases, blood diseases, sleep disorders, lung diseases, cardiovascular diseases, and translational science related to these conditions. The funding instrument is a grant with a minimum award of $300,000. The application deadline is November 18, 2027.

View original listing